Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients

June 7, 2023 updated by: Renmin Hospital of Wuhan University
In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of colorectal postpolypectomy patients. The enrolled patients were divided into group A with intelligent surveillance system reminding though telephone and message, group B with intelligent surveillance system reminding though message, group C with manual reminder, and group D with natural state. The surveillance among the four groups were compared.

Study Overview

Detailed Description

The adherence of doctors to published colorectal post-polypectomy surveillance guidelines varies greatly, and patient follow-up is critical but time-consuming. Previous studies we developed an automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients in time. In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of colorectal postpolypectomy patients. The enrolled patients were divided into group A with intelligent surveillance system reminding though telephone and message, group B with intelligent surveillance system reminding though message, group C with manual reminder, and group D with natural state. The surveillance among the four groups were compared.

Study Type

Interventional

Enrollment (Estimated)

1644

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430060
        • Renmin Hospital of Wuhan University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male or female aged 18 years or older who undergo colonoscopy.

Exclusion Criteria:

  • 1)No pathological result.
  • 2) No or invalid contact information.
  • 3) The surveillance interval cannot be determined according to the surveillance guidelines, including poor bowel preparation, colorectal cancer or suspicious malignance, surgery or colorectal ESD history, those who fail to complete colonoscopy due to unbearable, pathological indications of not polyps, hamartoma or lymphoma polyps, history of ulcerative colitis, and so on.
  • 4) Has participated in other clinical trials, signed the informed consent form and is in the surveillance period of other clinical trials.
  • 5) Have drug or alcohol abuse or psychological disorder in the past five years.
  • 6)Pregnancy.
  • 7)Not suitable for recruitment after investigator evaluation because of other high-risk conditions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Normal group
The patients in the control group were observed in the clinical natural state of surveillance without automatic surveillance system or manual reminder.
Experimental: With automatic surveillance system reminding through telephone and message
Patients were reminded of the surveillance time by an automatic surveillance system after the endoscopic and pathological results were available and before the surveillance time through telephone and message.
An automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times. AI based automatic surveillance (AS) system (ENDOANGEL-AS) reminds patients by telephone.
An automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times. AI based automatic surveillance (AS) system (ENDOANGEL-AS) reminds patients through message.
Experimental: With automatic surveillance system reminding through message
Patients were reminded of the surveillance time by an automatic surveillance system after the endoscopic and pathological results were available and before the surveillance time through message.
An automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times. AI based automatic surveillance (AS) system (ENDOANGEL-AS) reminds patients through message.
Experimental: With manual reminder
Patients were reminded of the surveillance time by manual reminder after the endoscopic and pathological results were available and before the surveillance time.
Medical staff remind patients manually .

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
On-time Surveillance Rate
Time Frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with on-time surveillance, and the denominator is the number of all colorectal postpolypectomy patients requiring surveillance.
From enrollment to study completion, assessed up to 3 years.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Advance Surveillance Rate
Time Frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with surveillance in advance, and the denominator is the number of all colorectal postpolypectomy patients requiring surveillance.
From enrollment to study completion, assessed up to 3 years.
Delayed Surveillance Rate
Time Frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with delayed surveillance, and the denominator is the number of all colorectal postpolypectomy patients requiring surveillance.
From enrollment to study completion, assessed up to 3 years.
lesion progression rate
Time Frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with lesion progression, and the denominator is the number of all surveillance colorectal postpolypectomy patients.
From enrollment to study completion, assessed up to 3 years.
lesion persistence rate
Time Frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with lesion persistence, and the denominator is the number of all surveillance colorectal postpolypectomy patients.
From enrollment to study completion, assessed up to 3 years.
lesion regression rate
Time Frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with lesion regression, and the denominator is the number of all surveillance colorectal postpolypectomy patients.
From enrollment to study completion, assessed up to 3 years.
The incidence rate of colorectal cancer
Time Frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with colorectal cancer in surveillance colonoscopy, and the denominator is the number of all surveillance colorectal postpolypectomy patients.
From enrollment to study completion, assessed up to 3 years.
Surveillance Rate
Time Frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with surveillance, and the denominator is the number of all colorectal postpolypectomy patients requiring surveillance.
From enrollment to study completion, assessed up to 3 years.
The accuracy of identifing post-polypectomy patients
Time Frame: 1 day At the time of enrollment
The numerator is the number of patients correctly identified by automated surveillance system, and the denominator is the number of all enrolled colorectal postpolypectomy patients.
1 day At the time of enrollment
The accuracy of classifying risk levels
Time Frame: 1 day At the time of enrollment
The numerator is the number of patients correctly classified by automated surveillance system, and the denominator is the number of all enrolled colorectal postpolypectomy patients.
1 day At the time of enrollment
The accuracy of assigning surveillance intervals
Time Frame: 1 day At the time of enrollment
The numerator is the number of patients correctly assigned by automated surveillance system, and the denominator is the number of all enrolled colorectal postpolypectomy patients.
1 day At the time of enrollment
The incidence rate of early colorectal cancer
Time Frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with early colorectal cancer in surveillance colonoscopy, and the denominator is the number of all surveillance colorectal postpolypectomy patients.
From enrollment to study completion, assessed up to 3 years.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: yuhonggang1969@163.com Yu, phD, Renmin Hospital of Wuhan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2023

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2029

Study Registration Dates

First Submitted

May 31, 2023

First Submitted That Met QC Criteria

June 7, 2023

First Posted (Actual)

June 8, 2023

Study Record Updates

Last Update Posted (Actual)

June 8, 2023

Last Update Submitted That Met QC Criteria

June 7, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • EA-19-003-29

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Artificial Intelligence

Clinical Trials on AI based automatic surveillance (AS) system (ENDOANGEL-AS) reminds the patients through by telephone .

Subscribe